Patients with inflammatory bowel diseases (IBDs) are at increased risk of colorectal cancer (CRC). Persistent inflammation is hypothesized to increase risk of CRC in patients with IBD; however, the few studies in this area have been restricted to cross-sectional assessments of histologic severity. Publishing in Clinical Gastroenterology and Hepatology, Ashwin N.

READ FULL ARTICLE Curated publisher From Gastro